mRNA Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030

mRNA Vaccine Trends and Forecast

The future of the global mRNA vaccine market looks promising with opportunities in the hospital & clinic and research laboratory markets. The global mRNA vaccine market is expected to reach an estimated $26.8 billion by 2030 with a CAGR of 8.3% from 2024 to 2030. The major drivers for this market are soaring demand for new vaccines and therapeutics and rising cases of chronic and infectious diseases.

A more than 150-page report is developed to help in your business decisions.

mRNA Vaccine by Segment

The study includes a forecast for the global mRNA vaccine by type, application, end use, and region.

mRNA Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Self-Amplifying mRNA Vaccines (SAM)
• Conventional Non-Amplifying mRNA Vaccines

mRNA Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Cancer Immunotherapy
• Allergy Tolerization
• Therapeutic Vaccines

mRNA Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Research Laboratories
• Others

mRNA Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of mRNA Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies mRNA vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the mRNA vaccine companies profiled in this report include-

• Pfizer
• Moderna
• BioNTech
• GlaxoSmithKline
• Daiichi Sankyo

mRNA Vaccine Market Insights

Lucintel forecasts that cancer immunotherapy is expected to witness highest growth over the forecast period.

Within this market, hospital & clinic will remain the largest segment due to growing patients preference for this facilities because of the convenient access to vaccinations, availability of trained medical personnel, and existence of advanced healthcare infrastructure.

North America will remain the largest regiondue to augmenting prevalence of infectious diseases among population, existence of robust healthcare infrastructure, and presence of key players in the region.

Features of the Global mRNA Vaccine Market

Market Size Estimates: mRNA vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: mRNA vaccine market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: mRNA vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the mRNA vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the mRNA vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the mRNA vaccine market size?

Answer: The global mRNA vaccine market is expected to reach an estimated $26.8 billion by 2030.

Q.2 What is the growth forecast for mRNA vaccine market?

Answer: The global mRNA vaccine market is expected to grow with a CAGR of 8.3% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the mRNA vaccine market?

Answer: The major drivers for this market are soaring demand for new vaccines and therapeutics and rising cases of chronic and infectious diseases.

Q4. What are the major segments for mRNA vaccine market?

Answer: The future of the mRNA vaccine market looks promising with opportunities in the hospital & clinic and research laboratory markets.

Q5. Who are the key mRNA vaccine market companies?

Answer: Some of the key mRNA vaccine companies are as follows:

• Pfizer
• Moderna
• BioNTech
• GlaxoSmithKline
• Daiichi Sankyo

Q6. Which mRNA vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that cancer immunotherapy is expected to witness highest growth over the forecast period.

Q7. In mRNA vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest regiondue to augmenting prevalence of infectious diseases among population, existence of robust healthcare infrastructure, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the mRNA vaccine market by type (self-amplifying mRNA vaccines (SAM) and conventional non-amplifying mRNA vaccines), application (cancer immunotherapy, allergy tolerization, and therapeutic vaccines), end use (hospitals & clinics, research laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?